Φορτώνει......
Comparative Effectiveness of Carboplatin-Pemetrexed With vs Without Bevacizumab for Advanced Non-Squamous Non-Small Cell Lung Cancer
INTRODUCTION: Despite recent advances in targeted therapy and immunotherapy for advanced non-small cell lung cancer (NSCLC), carboplatin-pemetrexed-bevacizumab remains a commonly used first-line regimen. However, it is unknown whether the addition of bevacizumab to carboplatin-pemetrexed improves ov...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | J Natl Compr Canc Netw |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6661525/ https://ncbi.nlm.nih.gov/pubmed/31085759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6004/jnccn.2018.7102 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|